DOND; Bharat

Patent Applications and Registrations

Patent applications and USPTO patent grants for DOND; Bharat.The latest application filed is for "1,6- diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections".

Company Profile

3.8.11

DOND; Bharat - Aurangabad IN
DOND; Bharat - Maharashtra IN
DOND; Bharat - Aurangabad - 6 Maharashtra
Dond; Bharat - Aurangabad 0 IN
DOND; Bharat - Aurangabad 431006 IN
Dond; Bharat - Ahmednagar IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1,6- Diazabicyclo [3,2,1] Octan-7-one Derivatives And Their Use In The Treatment Of Bacterial Infections App 20200071328 - PATIL; Vijaykumar Jagdishwar ; et al.	2020-03-05
1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their bacterial infections Grant 10,519,155 - Patil , et al. Dec	2019-12-31
Difluoro-(2-substituted Carbamoyl-1,6-diaza-bicyclo [3.2.1] Oct-6-yloxy) Acetic Acid Compounds And Their Use In Treatment Of Bacterial Infections App 20190077802 - PATIL; Vijaykumar Jagdishwar ; et al.	2019-03-14
7-Oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections (changed by PCT to: 7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS App 20180282331 - TADIPARTHI; Ravikumar ; et al.	2018-10-04
1,6- Diazabicyclo [3,2,1] Octan-7-one Derivatives And Their Use In The Treatment Of Bacterial Infections App 20180170930 - PATIL; Vijaykumar Jagdishwar ; et al.	2018-06-21
1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections Grant 9,732,081 - Patil , et al. August 15, 2	2017-08-15
Process for preparation of (2S, 5R)-1,6-diaza-bicyclo[3.2.1]octane-2-carbonitrile-7-oxo-6-(sulfooxy)-mono sodium salt Grant 9,663,518 - Patil , et al. May 30, 2	2017-05-30
Polymorphs and process for preparation of (2S, 5R)-7-oxo-N-[(2S)-pyrrolidin-2-yl-methyloxy]-6-(sulfooxy)-1,6-diazabicycl- o[3.2.1]octane-2-carboxamide Grant 9,604,986 - Tadiparthi , et al. March 28, 2	2017-03-28
1,6- Diazabicyclo [3,2,1] Octan-7-one Derivatives And Their Use In The Treatment Of Bacterial Infections App 20160311822 - PATIL; Vijaykumar Jagdishwar ; et al.	2016-10-27
Polymorphs And Process For Pretaration Of (2s,5r)-7-0x0-n-[(2s)-pyrrollidin-2-yl-methyloxy]-6-(sulfooxy)-1,6-diazab- Icyclo[3.2.1 ]octane-2-carboxamide App 20160289231 - TADIPARTHI; Ravikumar ; et al.	2016-10-06
1,6- Diazabicyclo [3,2,1] Octan- 7- One Derivatives And Their Use In The Treatment Of Bacterial Infections App 20160213655 - PATIL; Vijaykumar Jagdishwar ; et al.	2016-07-28
Process for preparation of ketolide intermediates Grant 9,206,214 - Patil , et al. December 8, 2	2015-12-08
1,6- Diazabicyclo [3,2,1] Octan-7-one Derivatives And Their Use In The Treatment Of Bacterial Infections App 20150203503 - Patil; Vijaykumar Jagdishwar ; et al.	2015-07-23
1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections Grant 9,006,230 - Bhagwat , et al. April 14, 2	2015-04-14
1,6-Diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections App 20140088068 - Bhagwat; Sachin ; et al.	2014-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.